Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
29 studies found for:    Porencephaly
Show Display Options
Rank Status Study
21 Completed Study Evaluating PD-0299685 for the Treatment of Vasomotor Symptoms (Hot Flashes / Flushes) Associated With Menopause
Condition: Hot Flashes
Intervention: Drug: PD-0299685
22 Completed
Has Results
Study on Safety and Efficacy of an Oral Contraceptive in Long Cycles
Condition: Contraception
Interventions: Drug: Flexible (extended) treatment of EE20/DRSP (YAZ, BAY86-5300);   Drug: Fixed extended treatment of EE20/DRSP (YAZ, BAY86-5300);   Drug: Standard 24+4 treatment of EE20/DRSP (YAZ, BAY86-5300)
23 Completed Efficacy and Safety Study of an Oral Contraceptive in Healthy Females
Condition: Contraception
Intervention: Drug: EV/DNG (Qlaira, BAY86-5027, SH T00658ID)
24 Suspended Transcranial Direct Current Stimulation in a Smoking Cessation Trial
Condition: Nicotine Dependence
Interventions: Device: active transcranial Direct Current Stimulation;   Device: sham transcranial Direct Current Stimulation
25 Recruiting Partnership for Applied Research in Fracture Prevention Programs for the Elderly
Condition: Osteoporosis With Current Fragility Fracture
Intervention: Other: Integrated program
26 Completed
Has Results
Cardiac Home Education and Support Trial (CHEST): A Pilot Study
Condition: Coronary Artery Disease
Intervention: Other: Peer Support
27 Completed
Has Results
Distribution of Bupropion and Varenicline to Increase Smoking Cessation Attempts
Conditions: Tobacco Use Disorder;   Smoking;   Smoking Cessation
Interventions: Drug: bupropion;   Drug: varenicline;   Behavioral: motivational emails
28 Completed
Has Results
Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding
Condition: Metrorrhagia
Interventions: Drug: Estradiol valerate/Dienogest (Natazia, Qlaira, BAY86-5027);   Drug: Placebo
29 Completed TOP: Trial of the Effect of Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
Condition: Osteoporosis
Intervention: Drug: ALX1-11

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-29) Next Page   
Indicates status has not been verified in more than two years